These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34392112)

  • 41. Evidence for nonlinear accumulation of the ultrapotent fentanyl analog, carfentanil, after systemic administration to male rats.
    Bergh MS; Bogen IL; Garibay N; Baumann MH
    Neuropharmacology; 2019 Nov; 158():107596. PubMed ID: 30965021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strategic Decision-Making by a Forensic Toxicology Laboratory in Response to an Emerging NPS: Detection, Quantitation and Interpretation of Carfentanil in Death Investigations in Ontario, Canada, July 2017 to June 2018.
    Solbeck P; Woodall KL; Martin TL
    J Anal Toxicol; 2021 Sep; 45(8):813-819. PubMed ID: 34166495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug checking identifies counterfeit alprazolam tablets.
    Tobias S; Shapiro AM; Grant CJ; Patel P; Lysyshyn M; Ti L
    Drug Alcohol Depend; 2021 Jan; 218():108300. PubMed ID: 33127185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Toxicity of designer benzodiazepines: A case of etizolam and cocaine intoxication.
    Drevin G; Briet M; Ferec S; Abbara C
    Forensic Sci Int; 2022 Jul; 336():111324. PubMed ID: 35525006
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detecting fentanyl using point-of-care drug checking technologies: A validation study.
    Ti L; Tobias S; Lysyshyn M; Laing R; Nosova E; Choi J; Arredondo J; McCrae K; Tupper K; Wood E
    Drug Alcohol Depend; 2020 Jul; 212():108006. PubMed ID: 32438280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ultrasound-assisted low-density solvent dispersive liquid-liquid microextraction for the determination of 4 designer benzodiazepines in urine samples by gas chromatography-triple quadrupole mass spectrometry.
    Meng L; Zhu B; Zheng K; Fu S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 May; 1053():9-15. PubMed ID: 28399467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening procedure for 38 fentanyl analogues and five other new opioids in whole blood by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Bakhmut Z; Mikolajczyk A
    J Appl Toxicol; 2020 Aug; 40(8):1033-1046. PubMed ID: 32103530
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gas Chromatography-Mass Spectrometry Analysis of Synthetic Opioids Belonging to the Fentanyl Class: A Review.
    Valdez CA
    Crit Rev Anal Chem; 2022; 52(8):1938-1968. PubMed ID: 34053394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The distribution and redistribution of carfentanil in post mortem samples.
    Chatterton CN; Handy RP; Shoemaker GK; Scott-Ham M
    Forensic Sci Int; 2020 Apr; 309():110215. PubMed ID: 32113175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Novel Synthetic Opioids U-47700, U-50488 and Furanyl Fentanyl by LC-MS/MS in Postmortem Casework.
    Mohr AL; Friscia M; Papsun D; Kacinko SL; Buzby D; Logan BK
    J Anal Toxicol; 2016 Nov; 40(9):709-717. PubMed ID: 27590036
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.
    Feasel MG; Wohlfarth A; Nilles JM; Pang S; Kristovich RL; Huestis MA
    AAPS J; 2016 Nov; 18(6):1489-1499. PubMed ID: 27495118
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A strategy for the detection of benzodiazepine drugs using low-resolution paper-spray mass spectrometry for harm reduction drug checking.
    Miskulin A; Wallace B; Gill C; Hore D
    Drug Test Anal; 2023 Dec; ():. PubMed ID: 38145889
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Point-of-care community drug checking technologies: an insider look at the scientific principles and practical considerations.
    Gozdzialski L; Wallace B; Hore D
    Harm Reduct J; 2023 Mar; 20(1):39. PubMed ID: 36966319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Not Carfentanil-A Case of Unexpected Xylazine Detection.
    Zheng JX; Randall S; Grimsrud K; Bainbridge S; Tran NK
    J Appl Lab Med; 2024 May; 9(3):629-634. PubMed ID: 38300830
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges.
    Patel DN; Li L; Kee CL; Ge X; Low MY; Koh HL
    J Pharm Biomed Anal; 2014 Jan; 87():176-90. PubMed ID: 23721687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Femoral blood concentrations of the designer benzodiazepine etizolam in post-mortem cases.
    Hikin LJ; Smith PR; Maskell PD; Kurimbokus H; Ashong E; Couchman L; Morley SR
    Med Sci Law; 2021 Apr; 61(2):122-129. PubMed ID: 33236683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Toward automated infrared spectral analysis in community drug checking.
    Gozdzialski L; Hutchison A; Wallace B; Gill C; Hore D
    Drug Test Anal; 2024 Jan; 16(1):83-92. PubMed ID: 37248686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development and validation of liquid chromatography-tandem mass spectrometry targeted screening of 16 fentanyl analogs and U-47700 in hair: Application to 137 authentic samples.
    Larabi IA; Martin M; Etting I; Pfau G; Edel Y; Alvarez JC
    Drug Test Anal; 2020 Sep; 12(9):1298-1308. PubMed ID: 32476263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discriminative stimulus effects of carfentanil in rats discriminating fentanyl: Differential antagonism by naltrexone.
    Flynn SM; France CP
    Drug Alcohol Depend; 2021 Apr; 221():108599. PubMed ID: 33631547
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Carfentanil Blood Concentrations in Impaired Driving Investigations in Ontario, Canada.
    Wallage HR; Elliot M; Rajotte JW
    J Anal Toxicol; 2022 Oct; 46(8):860-865. PubMed ID: 35715987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.